Eversense 365 Receives FDA Clearance: The World's First One Year CGM - Senseonics Holdings ( AMEX:SENS )
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring ( iCGM ) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM's for minimal life disruption
| Ticker |
Sentiment |
Impact |
|
DXCM
|
Neutral
|
2 %
|
|
PHCCF
|
Neutral
|
6 %
|
